Skip to content
Screener

Passage Bio, Inc. PASG Q3 2025 earnings

Reported November 10, 2025 · Before market open

EPS-$2.44Beat by $0.20
EPS estimate-$2.64

Next report

Nov 9, 2026 (in 2 months)
EPS estimate-$2.44

FAQ

When did Passage Bio, Inc. report Q3 2025 earnings?
Passage Bio, Inc. (PASG) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Passage Bio, Inc.'s Q3 2025 revenue and EPS?
Passage Bio, Inc. reported eps of $-2.44 for Q3 2025.
Did Passage Bio, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-2.64 by $0.20.
How did Passage Bio, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 687.1% from $-0.31.
Where can I find Passage Bio, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-109158) and the 10-Q periodic report (0001104659-25-109180) directly on SEC EDGAR. The filing index links above go to sec.gov.